Related Experiment Video

Updated: May 24, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

Trop-2 inhibits prostate cancer cell adhesion to fibronectin through the β1 integrin-RACK1 axis

Marco Trerotola1, Jing Li, Saverio Alberti

  • 1Department of Cancer Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.

Insights

Trop-2, a protein found in prostate cancer (PrCa), regulates cell adhesion to fibronectin by activating the β(1) integrin-RACK1-FAK-Src pathway, impacting cancer aggressiveness.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Trop-2 is a transmembrane glycoprotein often overexpressed in human carcinomas, including prostate cancer (PrCa).
  • While Trop-2's role in cell-cell adhesion is suggested by homology to Trop-1/EpCAM and binding to tight junction proteins, its function in extracellular matrix adhesion is unexplored.
  • PrCa aggressiveness is a critical factor in patient outcomes.

Purpose of the Study:

  • To investigate the role of Trop-2 in prostate cancer cell adhesion to the extracellular matrix.
  • To elucidate the molecular mechanisms by which Trop-2 influences cell adhesion and signaling pathways.

Main Methods:

  • Trop-2 expression was manipulated using shRNA-mediated silencing and ectopic expression in PrCa cell lines.
  • Cell adhesion assays were performed using fibronectin (FN) as the extracellular matrix ligand.
  • Western blotting and co-immunoprecipitation were used to analyze protein interactions and signaling pathway activation (β(1) integrins, RACK1, Src, FAK, IGF-IR).

Main Results:

  • Trop-2 expression in PrCa cells correlates with increased cancer aggressiveness.
  • Trop-2 expression inhibits PrCa cell adhesion to fibronectin, independent of α(v) β(5) integrin.
  • Trop-2 enhances the association of β(1) integrins with RACK1, promoting RACK1's translocation to the cell membrane.
  • Trop-2 activates Src and FAK signaling pathways via the β(1) integrin-RACK1 interaction, without involving IGF-IR.

Conclusions:

  • Trop-2 acts as a novel regulator of prostate cancer cell adhesion to fibronectin.
  • The mechanism involves the activation of the β(1) integrin-RACK1-FAK-Src signaling axis.
  • Trop-2's role in modulating cell adhesion and signaling pathways contributes to prostate cancer aggressiveness.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...